Why the study?
Does CTCA added to standard care improve symptoms and quality of life in patients with suspected angina?
Does CTCA added to standard care improve symptoms and quality of life in patients with suspected angina?
In patients with suspected angina, adding CTCA to standard care is associated with a small attenuation of improvements in symptoms and quality of life at 6 months, driven by the detection of moderate non-obstructive disease.
No takes yet. Share an insight, caveat, or question.
Adding CTCA to standard care attenuates symptom and QoL gains in suspected angina; challenges routine use for symptomatic benefit.
Williams et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: